» Articles » PMID: 29124493

Genotype Phenotype Correlation in Asian Indian Von Hippel-Lindau (VHL) Syndrome Patients with Pheochromocytoma/paraganglioma

Overview
Journal Fam Cancer
Publisher Springer
Specialty Oncology
Date 2017 Nov 11
PMID 29124493
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The data in genotype-phenotype correlation in Indian von Hippel-Lindau (VHL) patients is limited. We have retrospectively studied 31 genetically proven VHL patients with pheochromocytoma/paraganglioma (PCC/PGL) from families and have reviewed the World literature on PCC/PGL in patients with large VHL deletions. Three patients had large deletions and 28 patients had other mutations [missense mutations in 25, 3 bp deletion in 2 and single bp duplication in one]. Unilateral PCC were significantly more common in patients with large VHL deletions whereas multiple PCC (bilateral PCC or PCC + sympathetic PGL) were significantly more common in those with other mutations. World literature review confirmed the rarity of PCC/PGL in patients with large deletions and we report the first definitive case of PCC associated with complete VHL deletion. Pancreatic neuroendocrine tumours were more common, often metastatic and the most common cause of death in our cohort. Our study had eight parent off-spring pairs from five families. The off-springs were significantly younger at presentation and had significantly higher number of PCC/PGL. In conclusion, PCC/PGL are rare in patients with large VHL deletions and if occur are most likely to be solitary. Patients with bilateral PCC or multifocal PCC/PGL are least likely to have large VHL deletions. Our study also provides additional evidence for existence of the phenomenon of anticipation in VHL syndrome.

Citing Articles

The genetic differences between types 1 and 2 in von Hippel-Lindau syndrome: comprehensive meta-analysis.

Azimi F, Naseripour M, Aghajani A, Kasraei H, Chaibakhsh S BMC Ophthalmol. 2024; 24(1):343.

PMID: 39138406 PMC: 11323439. DOI: 10.1186/s12886-024-03597-1.


Neuroendocrine neoplasm: Current understanding.

Lila A, Memon S J Postgrad Med. 2023; 69(2):65-67.

PMID: 36960525 PMC: 10259434. DOI: 10.4103/jpgm.jpgm_51_23.


A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?.

Azimi F, Aghajani A, Khakpour G, Chaibakhsh S Mol Genet Genomics. 2022; 297(6):1615-1626.

PMID: 36006455 DOI: 10.1007/s00438-022-01940-z.


VHL mosaicism: the added value of multi-tissue analysis.

Oldfield L, Grzybowski J, Grenier S, Chao E, Downs G, Farncombe K NPJ Genom Med. 2022; 7(1):21.

PMID: 35304467 PMC: 8933488. DOI: 10.1038/s41525-022-00291-3.


The Genotype-Phenotype Association of Von Hipple Lindau Disease Based on Mutation Locations: A Retrospective Study of 577 Cases in a Chinese Population.

Qiu J, Zhang K, Ma K, Zhou J, Gong Y, Cai L Front Genet. 2020; 11:532588.

PMID: 33362845 PMC: 7762453. DOI: 10.3389/fgene.2020.532588.

References
1.
Crossey P, Richards F, Foster K, Green J, Prowse A, Latif F . Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet. 1994; 3(8):1303-8. DOI: 10.1093/hmg/3.8.1303. View

2.
Blansfield J, Choyke L, Morita S, Choyke P, Pingpank J, Alexander H . Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery. 2007; 142(6):814-8. PMC: 6771023. DOI: 10.1016/j.surg.2007.09.012. View

3.
Maher E, Yates J, Harries R, Benjamin C, Harris R, Moore A . Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990; 77(283):1151-63. DOI: 10.1093/qjmed/77.2.1151. View

4.
Tabori U, Nanda S, Druker H, Lees J, Malkin D . Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res. 2007; 67(4):1415-8. DOI: 10.1158/0008-5472.CAN-06-3682. View

5.
Cho H, Ki C, Kim J . Improved detection of germline mutations in Korean VHL patients by multiple ligation-dependent probe amplification analysis. J Korean Med Sci. 2009; 24(1):77-83. PMC: 2650969. DOI: 10.3346/jkms.2009.24.1.77. View